Leukotrienes and Other Products of the 5-Lipoxygenase Pathway

Franklin H. Epstein(Harvard University), Robert A. Lewis(Harvard University), K. Frank Austen, Roy J. Soberman
New England Journal of Medicine
September 6, 1990
Cited by 1,208

Abstract

THE slow-reacting substance of anaphylaxis was recognized as a discrete biologic entity 1 , 2 three to four decades before it was chemically defined as three specific cysteinyl leukotriene products of the 5-lipoxygenase pathway.3 4 5 6 7 In the interim, it was hypothesized that this moiety might function as a proinflammatory mediator of bronchoconstriction and vasopermeability in diseases of immediate hypersensitivity.8 9 10 11 Since the chemical characterization of the slow-reacting substance of anaphylaxis as several cysteinyl leukotrienes and the identification and biochemical assessment of the enzymes in the 5-lipoxygenase pathway (Fig. 1 and Glossary), the products of this pathway have been implicated in a much broader variety of functions . . .


Related Papers

No related papers found

Powered by citation graph analysis